COMPLETED

Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will evaluate the therapeutic efficacy of Neuro-World cognitive training games (Woorisoft, S. Korea) in patients with mild cognitive impairment.

Official Title

Towards the Development of a Mobile-health Technology Designed to Encourage the Use of Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic

Quick Facts

Study Start:2022-02-17

Study Completion:2025-03-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:COMPLETED

Study ID

NCT04920123

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:55 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Seventeen points or greater and smaller than twenty-six points on the Montreal Cognitive Assessment (MoCA) * Fifty-five years old and above * Minimal technological literacy (i.e. ability to use a tablet independently) * Having a computer for online videoconferencing-based communication (necessary for online cognitive assessments)	* Confounding neurological and psychiatric disorders * History of traumatic brain injury * Clinically known hearing or vision impairment * Severe upper-limb motor impairments that could impact the use of mobile devices * Clinical presentations suggestive of dementia with Lewy bodies, progressive supranuclear palsy, multiple system atrophy, or vascular parkinsonism * Diagnosis of dementia * Major depression * Any significant upper-limb impairment that could affect tablet use * Participation in any other therapist-supervised cognitive training

Inclusion Criteria

Exclusion Criteria

* Seventeen points or greater and smaller than twenty-six points on the Montreal Cognitive Assessment (MoCA)
* Fifty-five years old and above
* Minimal technological literacy (i.e. ability to use a tablet independently)
* Having a computer for online videoconferencing-based communication (necessary for online cognitive assessments)

* Confounding neurological and psychiatric disorders
* History of traumatic brain injury
* Clinically known hearing or vision impairment
* Severe upper-limb motor impairments that could impact the use of mobile devices
* Clinical presentations suggestive of dementia with Lewy bodies, progressive supranuclear palsy, multiple system atrophy, or vascular parkinsonism
* Diagnosis of dementia
* Major depression
* Any significant upper-limb impairment that could affect tablet use
* Participation in any other therapist-supervised cognitive training

Contacts and Locations

Principal Investigator

Sunghoon I Lee, PhD

PRINCIPAL_INVESTIGATOR

University of Massachusetts, Amherst

Study Locations (Sites)

University of Massachusetts, Amherst

Amherst, Massachusetts, 01003

United States

The State University of New Jersey, Rutgers

Newark, New Jersey, 07102

United States

Collaborators and Investigators

Sponsor: University of Massachusetts, Amherst

Sunghoon I Lee, PhD, PRINCIPAL_INVESTIGATOR, University of Massachusetts, Amherst

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-02-17

Study Completion Date2025-03-31

Study Record Updates

Study Start Date2022-02-17

Study Completion Date2025-03-31

Terms related to this study

Additional Relevant MeSH Terms

Mild Cognitive Impairment